| Eucrisa (crisaborole) / Pfizer |
NCT04214197: Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis |
|
|
| Active, not recruiting | 4 | 150 | US | Crisaborole 2% Top Oint | Massachusetts General Hospital, Pfizer | Atopic Dermatitis | 07/21 | 08/21 | | |
| Active, not recruiting | 4 | 24 | US | Crisaborole, Eucrisa, Hydrocortisone Ointment, Triamcinolone ointment, Aquaphor | Johns Hopkins University, Pfizer | Atopic Dermatitis, Eczema | 12/24 | 12/24 | | |
| Not yet recruiting | 2 | 37 | Europe | Eucrisa, Betnovate Cream, Crisaborole PF-06930164, 10949/0014, Ointment, Cream, Eucrisa, Betnovate Cream | Sheffield Teaching Hospitals NHS Foundation Trust, Pfizer Inc. | atopic eczema (synonym atopic dermatitis) and the adverse treatment side effect epidermal atrophy, atopic eczema (synonym atopic dermatitis) is a chronic, relapsing, inflammatory disease of the skin. Epidermal atrophy is skin thinning, Diseases [C] - Skin and Connective Tissue Diseases [C17] | | | | |
NCT05298033: Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo |
|
|
| Completed | 2 | 32 | US | Crisaborole 2 % Topical Ointment, Eucrisa, PF-07038124 0.01% topical ointment, NBUVB phototherapy, Narrow band UVB, Sham phototherapy, Vehicle | University of Colorado, Denver, Pfizer | Vitiligo | 04/24 | 04/24 | | |
NCT04800185: Characterizing Skin Microbiome Change in Atopic Dermatitis |
|
|
| Completed | 1 | 20 | US | Crisaborole 2% Top Oint, Skin Microbiome Swabs | University of California, Irvine, Pfizer | Atopic Dermatitis, Atopic Dermatitis Eczema | 04/22 | 04/22 | | |
NCT03770858: Wearable Skin Sensors to Assess Nocturnal Scratch Behavior |
|
|
| Completed | N/A | 23 | US | Crisaborole, Scratch sensor | Northwestern University, Pfizer | Atopic Dermatitis | 08/21 | 08/22 | | |
